176 related articles for article (PubMed ID: 23089069)
21. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiotherapy and volumetric-modulated arc therapy have distinct clinical advantages in non-small cell lung cancer treatment.
Zhang J; Yu XL; Zheng GF; Zhao F
Med Oncol; 2015 Apr; 32(4):94. PubMed ID: 25725813
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma.
Kataria T; Govardhan HB; Gupta D; Mohanraj U; Bisht SS; Sambasivaselli R; Goyal S; Abhishek A; Srivatsava A; Pushpan L; Kumar V; Vikraman S
J Cancer Res Ther; 2014; 10(4):871-7. PubMed ID: 25579521
[TBL] [Abstract][Full Text] [Related]
24. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiation therapy for pancreatic malignancies.
Ali AN; Dhabaan AH; Jarrio CS; Siddiqi AK; Landry JC
Med Dosim; 2012; 37(3):271-5. PubMed ID: 22189026
[TBL] [Abstract][Full Text] [Related]
26. Planning analysis for locally advanced lung cancer: dosimetric and efficiency comparisons between intensity-modulated radiotherapy (IMRT), single-arc/partial-arc volumetric modulated arc therapy (SA/PA-VMAT).
Jiang X; Li T; Liu Y; Zhou L; Xu Y; Zhou X; Gong Y
Radiat Oncol; 2011 Oct; 6():140. PubMed ID: 22014217
[TBL] [Abstract][Full Text] [Related]
27. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.
Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M
Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165
[TBL] [Abstract][Full Text] [Related]
28. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
Ling DC; Hess CB; Chen AM; Daly ME
Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis.
Kabolizadeh P; Kalash R; Huq MS; Greenberger JS; Heron DE; Beriwal S
Am J Clin Oncol; 2015 Aug; 38(4):401-4. PubMed ID: 24064747
[TBL] [Abstract][Full Text] [Related]
31. Intraindividual comparison of conventional three-dimensional radiotherapy and intensity modulated radiotherapy in the therapy of locally advanced non-small cell lung cancer a planning study.
Marnitz S; Stuschke M; Bohsung J; Moys A; Reng I; Wurm R; Budach V
Strahlenther Onkol; 2002 Nov; 178(11):651-8. PubMed ID: 12426677
[TBL] [Abstract][Full Text] [Related]
32. Dose comparisons for conformal, IMRT and VMAT prostate plans.
Sale C; Moloney P
J Med Imaging Radiat Oncol; 2011 Dec; 55(6):611-21. PubMed ID: 22141609
[TBL] [Abstract][Full Text] [Related]
33. The impact of induction chemotherapy on the dosimetric parameters of subsequent radiotherapy: an investigation of 30 consecutive patients with locally-advanced non-small cell lung cancer and modern radiation planning techniques.
Grant JD; Sobremonte A; Hillebrandt E; Allen PK; Gomez DR
Radiat Oncol; 2015 Jan; 10():32. PubMed ID: 25636372
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
[TBL] [Abstract][Full Text] [Related]
35. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation.
Han C; Schultheisss TE; Wong JY
Radiother Oncol; 2012 Feb; 102(2):315-20. PubMed ID: 21724284
[TBL] [Abstract][Full Text] [Related]
37. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
Koelbl O; Krieger T; Haedinger U; Sauer O; Flentje M
Strahlenther Onkol; 2004 Dec; 180(12):783-8. PubMed ID: 15592698
[TBL] [Abstract][Full Text] [Related]
38. Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer.
Van Benthuysen L; Hales L; Podgorsak MB
Med Dosim; 2011; 36(4):404-9. PubMed ID: 21377864
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric comparison of single-arc/partial-arc volumetric modulated arc therapy and intensity-modulated radiotherapy for peripheral and central lung cancer.
Akcay M; Etiz D; Duruer K; Bozdogan O; Ozen A
J Cancer Res Ther; 2021; 17(1):80-87. PubMed ID: 33723136
[TBL] [Abstract][Full Text] [Related]
40. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]